Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B Devereux, Sverre E Kjeldsen, Stevo Julius, Gareth Beevers, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe-Pedersen, Lars H Lindholm, Markku S Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, A Coats, LIFE study group

Research output: Contribution to journalArticle

4891 Citations (Scopus)
Original languageEnglish
Pages (from-to)995-1003
Number of pages9
JournalThe Lancet
Issue number9311
Publication statusPublished - 2002

Cite this